FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Feb 29, 2024 0 275
usnews Jul 4, 2024 0 273
usnews Jul 4, 2024 0 265
usnews Jul 4, 2024 0 261
usnews Jul 4, 2024 0 258